Supelco introduces HPLC column

By Wai Lang Chu

- Last updated on GMT

Supelco, a division of Sigma-Aldrich, introduces its HPLC Column,
which offers improved retention power and resolution for
difficult-to-separate analytes. The column becomes the latest in
the Ascentis' family range, adding to the flexibility needed for
sensitive MS applications.

The new Ascentis C8 HPLC Column can be run with high organic mobile phases, facilitating sample solubility as well as improving mass spectrometric detection.

With the addition of the C8 to the C18 and RP Amide (an embedded polar group phase) columns, the Ascentis column now offers a broad range of selectivities for method developers to choose.

The column is one member of the Ascentis family, which has the advantage of including improved stability for extremely long column life and ultra-low bleed for sensitive MS applications.

The short and fast columns multiply productivity through elevated performance and higher reproducibility.

"The Ascentis HPLC column product line now comprises three different surface chemistries for achieving separations over a wide selectivity range,"​ says Klaus Herick, European Sales development manager at Supelco.

"Customers can achieve optimal retention and selectivity by choosing the standard in RP- HPLC C18, the polar embedded RP-Amide that has a very different orthogonal selectivity compared to C18, or the new C8 phase that allows for superior retention of hydrophobic compounds."

Related topics Preclinical Research

Related news

Show more

Follow us


View more